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Abstract
Background: The diagnosis of associated choledocholithiasis prior to cholecystectomy for patients with gallstones
is important for the surgical decision and treatment efficacy. However, whether ultrasound is sufficient for
preoperative diagnosis of choledocholithiasis remains controversial, with different opinions on whether routine
magnetic resonance cholangiopancreatography (MRCP) is needed to detect the possible presence of common bile
duct (CBD) stones.
Methods: In this study, a total of 413 patients with gallstones who were admitted to the Department of General
Surgery of the First Affiliated Hospital of Harbin Medical University in China for a period of 3 years and underwent
both ultrasound and MRCP examinations were retrospectively analysed. After reviewing and screening these cases
according to the literature, 11 indicators including gender, age, alanine aminotransferase, aspartate aminotransferase,
total bilirubin, direct bilirubin, indirect bilirubin, alkaline phosphatase, γ-aminotransferase, CBD diameter, and concurrent
acute cholecystitis were selected and comparatively analysed.
Results: Among the 413 patients, a total of 109 cases showed concurrent gallstones and choledocholithiasis, accounting
for 26.39 % of all cases. Among them, 60 cases of choledocholithiasis were revealed by ultrasound examination,
accounting for 55.05 %, while 49 cases of choledocholithiasis were not detected by ultrasound examination but were
confirmed by MRCP instead (the missed diagnosis rate of ultrasound was 44.95 %). The results of statistical analysis
suggested that alanine aminotransferase, acute cholecystitis, and CBD diameter were the three most relevant factors for
missed diagnosis by ultrasound.
Conclusion: The accuracy of preoperative ultrasonography for the diagnosis of associated CBD stones for patients with
gallstones is not high. However, elevated alanine aminotransferase, concurrent acute cholecystitis, and CBD diameter
were identified as key factors that may affect the accuracy of the diagnosis. Thus, routine preoperative MRCP
examination is suggested for patients with gallstones to rule out possible concomitant CBD stones.
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Background
Cholelithiasis is a common disease requiring general
surgery, in which gallstones account for the vast majority
of procedures [1]. For patients with gallstones, approxi-
mately 5–15 % of cases are associated with choledocholithi-
asis [2–6]. With the development of medical technology,
laparoscopic cholecystectomy (LC) has be more and more
used for the treatment of gallstones [7]. However, during
treatment, common bile duct stones are often easily over-
looked. Thus, exploring an easy approach to preoperatively
clarify the presence of associated CBD stones has important
clinical implications.
Currently, patients with gallstones undergo ultrasonog-
raphy examination and hepatobiliary biochemical serum
analyses (bilirubin, alkaline phosphatase, etc.) as part of
routine preoperative screening for CBD stones [8–16].
However, according to the literature, the accuracy and
sensitivity of elevated liver enzymes in the diagnosis of
choledocholithiasis are not high [12–16]. Due to the im-
pact of intrahepatic bile duct stones, liver disease, and
various sources of inflammation, acute short-term death
of liver cells can result in the abnormal elevation of related
predictors for choledocholithiasis, thereby affecting the
diagnosis [2, 9, 10, 16]. Moreover, a large number of
studies have indicated that the accuracy of ultrasound
diagnosis of choledocholithiasis is not high [17–22]. When
the specific hepatobiliary indicators evaluated in serum
biochemical tests are abnormal, choledocholithiasis can-
not be ruled out even if the ultrasound result is normal
[20]. In particular, the accuracy of ultrasound is generally
ranges from 55–65 % [17–23]. As a result, the diagnosis of
choledocholithiasis by ultrasound and other conventional
methods is not reliable.
In numerous preoperative imaging examinations,
endoscopic retrograde cholangiopancreatography (ERCP)
showed the highest accuracy in the diagnosis of choledo-
cholithiasis, although this approach is invasive and expen-
sive, with poor popularity [9, 10, 19, 24], so it is generally
not a preferred option. The diagnostic accuracy of
endoscopic ultrasound (EUS) for choledocholithiasis is
similar to ERCP, but it needs special eqipments and
skilled doctors [25]. Because some calculi cannot be ana-
lysed with computed tomography (CT), this approach is
generally not used for the diagnosis of calculi [19, 26].
However, magnetic resonance cholangiopancreatography
(MRCP) showed a high accuracy in the diagnosis of cho-
ledocholithiasis [22–24, 27]. In particular, Freitas ML
reported that its accuracy is comparable to that of ERCP
and IOC, and its sensitivity and specificity were shown to
reach 95 % and 90 %, respectively [10, 19, 24].
Among all approaches tested, MRCP has been consid-
ered an accurate and convenient method for the diagnosis
of choledocholithiasis [17–24]. However, whether routine
MRCP should be performed for patients with gallstones is
considered controversial. Supporters of routine MRCP
examination, including Ferrari FS, believe that its accuracy
is comparable to that of ERCP and IOC and that it is a
reliable tool for the diagnosis of choledocholithiasis [19].
In addition, Chang JH indicated that MRCP was the
preferred examination method to assess CBD stones [22],
and Maccioni F et al. reported that MRCP has great
potential for development in the future and that it may
play a valuable role and an alternative to ERCP in bile duct
and pancreatic diseases [26]. On the other hand, the oppo-
nents of routine MRCP examination, such as Hoffmann C
et al. believe that abdominal ultrasound is a highly effi-
cient method for the preoperative diagnosis of gallbladder
and CBD stones with high accuracy [28]. Karki S et al.
reported that ultrasound was easy to operate, was non-
invasive and served as a very valuable examination
method for the diagnosis of obstructive jaundice
caused by CBD stones [29]. Although the accuracy of
choledocholithiasis diagnosis by MRCP has been clearly
demonstrated, Epelboym I et al. indicated that, among the
existing means of treatment, MRCP is expensive and
inefficient and therefore not recommended as a preferred
option [30]. Nebiker CA also stated that although MRCP
plays a certain role in screening before gallstone surgery,
it is not reasonable to routinely perform MRCP examin-
ation due to financial considerations [31].
Thus, it remains unclear whether limitations exist for
ultrasonography to be used in the preoperative diagnosis
of choledocholithiasis and whether routine MRCP is
necessary in such cases. To answer these questions, the
current study investigated the reliability of preoperative
ultrasonography and the necessity of routine MRCP by
performing a retrospective analysis with statistical methods.
Methods
Subjects
The participant information was anonymous and taken
from the hospital database. This study was performed in
accordance with the Helsinki II declaration and the ap-
proval for this study was obtained from the Committee
for Medical Research Ethics of the First Affiliated
Hospital of Harbin Medical University, which are the
authority of research ethics in China.
A total of 413 patients with gallstones who were
admitted to the Department of General Surgery of the
First Affiliated Hospital of Harbin Medical University in
China from January 1, 2011 to December 31, 2013 and
underwent both ultrasound and MRCP examinations
were retrospectively analysed. Of these patients, 109 met
the criteria for this study and were included as subjects.
The inclusion criteria consisted of a diagnosis of concur-
rent gallstone and choledocholithiasis, the administra-
tion of both ultrasound and MRCP examinations, and
the presence of complete clinical data (complete medical
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record, liver function, MRCP, ultrasound, etc.). The
exclusion criteria consisted of the absence of MRCP, lack
of a choledocholithiasis diagnosis, liver disease or bile
duct cancer, and a history of biliary tract surgery.
Patients grouping
Patients with gallstones who were admitted to the
Department of General Surgery in our hospital for
treatment were divided into two groups. Those with
CBD stones revealed by both ultrasound and MRCP
examinations, who were diagnosed as associated choled-
ocholithiasis after subsequent clinical treatment, were
included in the group defined as the ultrasonic detection
group. Gallstone patients showing no obvious abnormal-
ities in CBD revealed by ultrasound, with CBD stones
revealed by MRCP examination, and who were diag-
nosed as associated choledocholithiasis after subsequent
clinical treatment were included in the group defined as the
ultrasound missed diagnosis group. This study evaluated a
total of 109 gallstone patients with associated choledocholi-
thiasis. The ultrasound missed diagnosis group included 49
cases of CBD stones that were revealed by MRCP but not
ultrasound. In this group, 7 cases showed no corresponding
clinical symptoms and presented normal laboratory exam-
ination results except for the MRCP examination; these pa-
tients were excluded due to the lack of relevant evidence
for this study. Thus, the remaining 42 cases were included
in the ultrasound missed diagnosis group. The ultrasound
detection group included 60 cases. To perform comparative
analysis with the ultrasound missed diagnosis group, 42
cases were randomly selected.
Outcome measures
(1) Gender: a categorical variable, male was presented
as 1, and female was presented as 2.
(2) Age: a counting variable, the age of the patient
at admission was recorded and rounded up to
the closest integer.
(3) Indicators of liver function, including alanine
aminotransferase (U/L), aspartate aminotransferase
(U/L), total bilirubin (μmol/L), direct bilirubin
(μmol/L), indirect bilirubin (μmol/L), alkaline
phosphatase (U/L), and γ-aminotransferase (U/L):
counting variables, the data from the first test of
liver function after the patient was admitted to
the hospital were recorded. Some patients had
previously obtained laboratory data pertaining to
liver function; those reference data that were
considered valuable for diagnosis and treatment
were recorded as reliable data.
(4) Acute cholecystitis: a categorical variable, acute
cholecystitis was recorded as 1, and no acute
cholecystitis was recorded as 0.
(5) CBD diameter: a counting variable, the data from
the first MRCP examination after the patient was
admitted to the hospital were recorded.
Statistical methods
All relevant data were statistically analysed using SPSS11.5
software. Different groups of data were analysed with
appropriate statistical methods. For instance, counting
data were compared using the chi-square test to detect if
the difference was significant, while categorical data were
compared using t-tests to detect whether the difference
was significant. The significance level was set as α = 0.05.
When p ≤ 0.05, the difference was considered statistically
significant. Differences in data on relevant indicators were
also analysed for significance. With univariate logistic
regression analysis, the odds ratio (OR) and Wald value of
each research factor of the 11 indicators were calculated,
and those indicators showing statistical significance were
selected. Then, further correlation analysis was carried out
for the 11 indicators to select the indicators with statisti-
cally significant correlations with each other. Finally, cor-
relation analysis was performed for the primary variable.
Results
A total of 413 patients with gallstones who were admitted
to the Department of General Surgery of the First
Affiliated Hospital of Harbin Medical University in China
from January 1, 2011 to December 31, 2013 and who
underwent both ultrasound and MRCP examinations were
retrospectively analysed. A total of 109 patients showed
concurrent gallstones and choledocholithiasis, accounting
for 26.39 % of all cases. Among these, 60/109 cases of cho-
ledocholithiasis were revealed by ultrasound examination,
accounting for 55.05 %, while 49 cases showed no abnor-
mality in the ultrasound examination. Seven cases showed
normal results in the routine laboratory examination, with
the exception of a CBD stone found by MRCP examin-
ation, accounting for 1.69 % of all cases and 6.42 % of the
cases with choledocholithiasis.
Analysis of the significance of the difference between the
two groups of data using SPSS
Univariate logistic regression analysis
Univariate logistic regression analysis was carried out for
the 11 indicators Table 1, and three indicators were found
to be statistically significant (p < 0.05). These significant
indicators included alanine aminotransferase, acute chole-
cystitis, and CBD diameter, as shown in Table 2.
Correlation analysis
To extend these results, correlation analysis was further
performed for the 11 indicators. This analysis showed
that p > 0.05 for all indicators, and the correlation coeffi-
cient <0.5, indicating no significant correlation, as shown
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in Table 3. The individual correlation analysis for the
three indicators with significant differences between the
two groups showed that, for these three indicators,
P > 0.05 and the correlation coefficient <0.5, indicating
no significant correlation, as shown in Table 4.
Correlation analysis for the primary variable
Correlation analyses for the three indicators with signifi-
cant differences between the two groups and the primary
variable were carried out. These results showed that
alanine aminotransferase and acute cholecystitis were
positively correlated with the primary variable, while the
diameter of the CBD was negatively correlated with the
primary variable. In other words, higher levels of alanine
aminotransferase were associated with an increased
likelihood of missed diagnosis of choledocholithiasis by
ultrasound. In addition, the likelihood of missed diagno-
sis of CBD stones by ultrasound was higher in patients
with acute cholecystitis, and CBD diameters closer to
normal were associated with a greater likelihood of
missed diagnosis of CBD stones by ultrasound, as shown
in Table 4.
Discussion
Cholelithiasis is a common disease requiring general
surgery, and due to the rapid development of medical
technology, its diagnosis and treatment have gradually
matured. However, the biliary system is extremely com-
plex, and there remains no standard for the diagnosis of
cholelithiasis.
In this study, information pertaining to patients with
concurrent gallstones and choledocholithiasis was
collected and analysed to investigate the reliability of
ultrasound in the diagnosis of concurrent gallstones and
choledocholithiasis, as well as the necessity of routine
MRCP. Retrospective analysis of the collected cases
showed that, among a total of 413 patients with gall-
stones who were admitted to the Department of General
Surgery of our hospital within 3 years and underwent
both ultrasound and MRCP examinations, 109 cases
showed concurrent gallstones and choledocholithiasis,
accounting for 26.39 % of all cases. Among these, 60
cases of choledocholithiasis were revealed by ultrasound
examination, with a detection rate of 55.05 %, while the
remaining 49 cases of choledocholithiasis were not de-
tected by ultrasound examination (the missed diagnosis
rate of ultrasound was 44.95 %). The above conclusion
suggests that ultrasound is not a reliable method for the
preoperative screening of CBD stones.
By reviewing the literature, 11 observation indicators
were selected for further analysis. The statistical baseline
description and analysis of the differences between the
two groups showed that three indicators, including
alanine aminotransferase, acute cholecystitis, and CBD
diameter, were significantly different between the two
groups. In addition, univariate logistic regression analysis
for the 11 indicators showed that these three indicators
were statistically significant, and correlation analysis for
these three indicators with statistical significance showed
no statistically significant correlation between them.
In particular, the correlation analysis for these three
indicators and “ultrasound missed diagnosis of CBD
stones” as the primary variable showed that alanine
aminotransferase and acute cholecystitis were positively
correlated with the primary variable, while CBD diameter
was negatively correlated with the primary variable.
Regarding the hepatobiliary indicators of serum bio-
chemistry, the levels of bilirubin and alkaline phosphatase
are considered to be significantly related to CBD stones.
In recent years, γ-aminotransferase has attracted increas-
ing attention, with a level greater than 90 U/L considered
a risk factor for CBD stones [8, 10, 15, 16, 32, 33]. In this
retrospective study, the levels of bilirubin, alkaline phos-
phatase, and γ-aminotransferase in the two groups of
subjects were significantly increased, suggesting that they
are closely related to the occurrence of CBD stones.
Table 1 Univariate logistic regression analysis of the 11 indicators
No. Indicator Odds ratio (OR) Wald value P value
1 Gender 9.214 (1.363,62.285) 5.187 0.182
2 Age 1.015 (0.954,1.078) 0.214 0.192
3 Alanine aminotransferase 1.001 (0.992,1.009) 0.019 0.037
4 Aspartate aminotransferase 1.007 (1.000,1.014) 3.599 0.154
5 Total bilirubin 0.981 (0.868,1.108) 0.094 0.303
6 Direct bilirubin 1.019 (0.872,1.193) 0.058 0.454
7 Indirect bilirubin 0.976 (0.85 9,1.108) 0.145 0.760
8 Alkaline phosphatase 1.000 (0.997,1.003) 0.007 0.906
9 γ-aminotransferase 1.001 (0.998,1.004) 0.222 0.521
10 Acute cholecystitis 0.085 (0.012,0.599) 6.130 0.001
11 CBD diameter 0.017 (0.002,0.137) 14.705 0.001
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Alanine aminotransferase 0.111>0.05 0.044>0.05
Aspartate aminotransferase 0.187>0.05 0.022>0.05 0.184>0.05
Total bilirubin 0.071>0.05 −0.107>0.05 0.278<0.05* −0.016>0.05
Direct bilirubin 0.073>0.05 −0.201>0.05 0.310<0.05 0.005>0.05 0.904<0.05*
Indirect bilirubin −0.068>0.05 0.072>0.05 0.214>0.05 0.010>0.05 0.625<0.05* 0.323<0.05*
Alkaline phosphatase 0.329<0.05* −0.024>0.05 0.178>0.05 −0.054>0.05 0.086>0.05 0.160>0.05 −0.098>0.05
γ-aminotransferase 0.169>0.05 0.021>0.05 0.440<0.05* −0.018>0.05 0.249>0.05 0.283<0.05* 0.087>0.05 0.427<0.05*
Acute cholecystitis 0.243>0.05 0.021>0.05 0.221>0.05 0.100>0.05 0.155>0.05 0.040>0.05 0.073>0.05 −0.015>0.05 0.166>0.05
CBD diameter 0.011>0.05 0.335<0.05* 0.191>0.05 0.319<0.05* −0.194>0.05 −0.109>0.05 −0.205>0.05 −0.070>0.05 −0.041>0.05 0.065>0.05













However, these three indicators were not significantly dif-
ferent between the two groups. Regarding the relationship
between alanine aminotransferase and CBD stones, few
relevant studies are available in the literature, mainly due
to poor specificity. Padda MS et al. reported that alanine
aminotransferase, alkaline phosphatase, and CBD diameter
are important for the diagnosis of concurrent gallstones
and CBD stones [13]. Similarly, Sharara AI et al. found that
elevated alanine aminotransferase and aspartate amino-
transferase levels were related to the timing of the pain
caused by CBD stones [34]. To date, the relationship be-
tween the alanine aminotransferase level and an ultrasound
missed diagnosis of CBD stones has not been reported.
Considering the limitations of this study, the relationship
between alanine aminotransferase and ultrasound missed
diagnosis of CBD stones remains poorly defined.
The relationship between acute cholecystitis and CBD
stones had been reported in many studies, with many
reports showing acute cholecystitis to be a significant
clinical symptom of choledocholithiasis. Tsai TJ et al.
reported that acute cholecystitis is one of the severe
concurrent complications of the recurrence of choledo-
cholithiasis after treatment [35], and Boys JA et al. indi-
cated that, in the case of choledocholithiasis associated
with acute cholecystitis, the diagnosis of CBD stones
based on the CBD diameter by ultrasound is not reliable
[35]. Acute cholecystitis can cause significant clinical
symptoms, but because of its rapid development, the
body quickly responds to stress, leading to significant
changes in the value of certain indicators, thereby masking
the CBD stones. Wong HP et al. proposed that MRCP is
the best method to diagnose acute cholecystitis associated
with choledocholithiasis [9], and Lee JK et al. indicated
that the CBD diameter and bilirubin level were related to
the development of acute cholecystitis. It is generally
agreed that there is a relationship between the occur-
rences of acute cholecystitis and choledocholithiasis,
although no relationship between acute cholecystitis and a
diagnosis of choledocholithiasis missed by ultrasound has
been reported [33]. Although this study confirmed the
relationship between these variables using statistical
methods, the mechanism for how acute cholecystitis
affects the ultrasound diagnosis of choledocholithiasis
remains unclear, and further investigation is needed.
In contrast, the relationship between CBD diameter
and CBD stones is more clear, as a larger CBD diameter
is one of the major risk factors for CBD stones. However,
a large number of studies have shown that the diameter of
the CBD is not positively correlated with the occurrence
of CBD stones [36–38]. For instance, the study by
Isherwood J et al. showed that only 37 % of patients with
choledocholithiasis presented a widened CBD diameter on
ultrasound. In addition, these authors suggested that if the
indicators of liver function related to choledocholithiasis
are abnormal, choledocholithiasis must be further
excluded even if the ultrasound shows a normal CBD
diameter [20]. Laing FC et al. demonstrated that at least
30 % of CBD stones showed no dilatation of CBD, and
ultrasound was unable to diagnose these patients, which
was likely affected by many factors [21]. Wong HP et al.
also indicated that the correlation between CBD diameter
and associated CBD stones was not as strong as previously
thought, as ultrasound can only provide data limited to
the CBD area, with only a limited ability to directly
measure the diameter of a CBD stone [9]. In addition,
Karvonen J reported that the CBD diameter did not
predict the progression of CBD stones [39]. The problems
addressed in the above studies are consistent with the
findings of our study; a nearly normal CBD diameter did
not reflect the absence of CBD stones, which may easily
mislead physicians and result in the missed diagnosis of
CBD stones.
At present, MRCP, ERCP, EUS, intraoperative cholan-
giography and intraoperative choledochoscopy are the
effective methods for diagnosis of choledocholithiasis
[26, 28, 40, 41]. Ainsworth AP et al. [41] and Meagher
et al. [42] considered that ERCP advantaged in the
diagnosis of common bile duct diseases. ERCP is a
traumatogenic examination that required professional
hospital equipment so it is not fit for screening a large
number of patients. However, MRCP is a nontraumato-
genic examination that can be finished in one day before
the operation and the average cost of the examination is
88 dollars in China. More over, MRCP has no obvious
effect on the cost of patients and the length of hospital
stay. So, MRCP is a feasible examination of screening
the suspected choledocholithiasis patients and it could









Common bile duct diameter 0.191>0.05* 0.065>0.05*
*P > 0.05 indicates no statistically significant correlation between the two
indicators
Table 4 Correlation analysis for the primary variable (missed












P value 0.038* 0.001* 0.000*
*P < 0.05 indicates statistically significant correlation between the indicator
and the primary variable
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bring the economic benefit. Morris S et al. [40] consid-
ered ERCP, compared to MRCP and EUS, was the most
effective diagnostic methods of choledocholithiasis
through analyzing the sensitivity of the examinations,
the average cost and quality of life. However, Vergel YB
et al. [43] considered MRCP was better than ERCP in
saving the cost and improving patients’ postoperative
quality of life for the suspected choledocholithiasis
patients through comparing with each other.
Among the cases included in this study, 7 cases showed
normal results for routine laboratory examinations, with
the exception that a CBD stone was revealed by MRCP
examination, accounting for 1.69 % of all cases and 6.42 %
of the cases with choledocholithiasis. This strong conceal-
ment may lead to serious consequences, and although its
proportion was as low as 1.69 % of all cases, the resulting
problem can not be ignored.
Based on this study, the importance of preoperative
MRCP examination was clearly demonstrated. This
approach is convenient and accurate, non-invasive and
safe. With increasing economic development and atten-
tion on public health, the cost of MRCP examination
should be acceptable.
Epelboym I, Nebiker CA, who believe that because of
the economic burden caused by MRCP, MRCP is not
recommended for choledocholithiasis preferred to be
checked [31, 32]. However, after the above discussion,
we can not be ignored that MRCP has its advantages in
screening patients with suspected choledocholithiasis in.
This article does not investigation and analysis cost
effective for patients. However, according to a basic
understanding of the Chinese MRCP average cost of 350
yuan, with an average economic comparison of China’s
national conditions and the world, with MRCP gallstone
patients with suspected choledocholithiasis screening is
feasible in economic benefits.
Conclusion
The accuracy of preoperative ultrasonography in the
diagnosis of patients with concurrent gallstones and
CBD stones is not high. In particular, elevated alanine
aminotransferase, acute cholecystitis, and nearly normal
CBD diameters were identified as key factors that may
affect the accuracy of its diagnosis. Thus, routine
preoperative MRCP examination is recommended for
patients with gallstones to rule out the likelihood of
concomitant CBD stones.
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